captopril has been researched along with aspirin in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (14.08) | 18.7374 |
1990's | 26 (36.62) | 18.2507 |
2000's | 19 (26.76) | 29.6817 |
2010's | 15 (21.13) | 24.3611 |
2020's | 1 (1.41) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Averbuch, M; Finkelstein, A; Greenland, M; Kornowski, R; Lehrman, H; Levo, Y; Pines, A; Schwartz, D | 1 |
Dietz, R; Nagel, F; Osterziel, KJ | 2 |
Braunwald, E; Hamm, P; Lamas, GA; Pfeffer, MA; Rouleau, JL; Wertheimer, J | 1 |
Grodzińska, L; Gryglewski, RJ; Swies, J; Sławiński, M | 1 |
Bird, HA; Dixon, JS; Wright, V | 1 |
Masotti, G | 1 |
Chiba, S; McGiff, JC; Quilley, CP; Quilley, J | 1 |
Gryglewski, RJ | 1 |
Melli, M; Türker, RK | 1 |
Harada, Y; Katori, M; Tanaka, K; Uchida, Y; Ueno, A | 1 |
de Jong, W; Nijkamp, FP | 1 |
Provoost, AP | 1 |
DiNicolantonio, R; Dusting, GJ; Hutchinson, JS; Mendelsohn, FA | 1 |
Ercan, ZS; Ersoy, A; Türker, RK; Zengil, H | 1 |
de Graeff, PA; Lie, KI; Smit, AJ; van der Broek, SA; van Gilst, WH; van Veldhuisen, DJ; van Wijngaarden, J; Wesseling, H | 1 |
Carretero, OA; Longhurst, JC; Pan, HL; Rendig, SV; Stahl, GL | 1 |
Giles, TD | 1 |
Banisadr, F; Buzelin, F; Grolleau, JY; Hamidou, MA; Jego, P; Moreau, A; Testa, A | 1 |
Montgomery, HE; Speechly-Dick, ME | 1 |
Basta, L; Braunvald, Iu; Dévis, BR; Fleĭker, GS; Geltman, EM; Goldman, S; Kaddi, TE; Moĭe, LA; Pfeffer, MA | 1 |
Preobrazhenskiĭ, DV | 1 |
Abdel-Haq, B; Favilla, S; Magagna, A; Salvetti, A; Taddei, S | 1 |
Aikawa, J; Akatsuka, N; Fukazawa, M; Hara, K; Ishikawa, M; Moroi, M; Namiki, A; Yamaguchi, T | 1 |
Luís, AS; Mourão, L; Neves, JL; Santos, AL; Santos, JM | 1 |
Coffman, TM; Smith, SR; Svetkey, LP | 1 |
Anderson, WP; Heguilen, RM; Woods, RL | 1 |
Bode-Böger, SM; Böger, RH; Frölich, JC; Gutzki, FM; Kramme, P; Tsikas, D | 1 |
Anthonio, RL; Crijns, HJ; de Kam, PJ; Kingma, JH; Oosterga, M; van Gilst, WH | 1 |
Brañas, F; García-Porrúa, C; González-Gay, MA | 1 |
Lee, TH | 1 |
Davie, AP | 1 |
Stojic, D | 1 |
Fine, EJ | 1 |
Battler, A; Behar, S; Boyko, V; Goldbourt, U; Gottlieb, S; Leor, J; Reicher-Reiss, H | 1 |
Deliyska, B; Kostadinova, I; Krtasteva, R; Simeonova, A | 1 |
Gambhir, S; Kher, V; Maini, A; Singhal, M | 1 |
Beutler, JJ; de Klerk, JM; Koomans, HA; Mertens, IJ; van de Ven, PJ | 1 |
Cağlar, M; Duranay, M; Erdem, Y; Ergün, EL; Uğur, O; Usalan, C | 1 |
Cohen, L; Habib, G | 1 |
Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ | 1 |
Da Luz, PL; Pamplona, D; Park, M; Ramires, JA; Silva, SR; Viecili, PR | 1 |
Bollwein, H; Steffen, S; Stolla, R; Weber, F | 1 |
Saxena, PR; Schoemaker, RG; Van Kerckhoven, R; van Veghel, R | 1 |
Jhund, PS; MacIntrye, IM; McMurray, JJ | 1 |
Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
Farhang, S; Javadzadegan, H; Mehdizadeh Baghbani, J | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 2 |
Mohebbati, R; Niazmand, S; Paseban, M; Sahebkar, A; Sathyapalan, T | 1 |
5 review(s) available for captopril and aspirin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
[Secondary prevention after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Captopril; Humans; Myocardial Infarction | 1993 |
Interventions in renal scintirenography.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hydronephrosis; Hypertension, Renal; Iodine Radioisotopes; Iodohippuric Acid; Kidney; Male; Radioisotope Renography; Technetium Tc 99m Mertiatide; Technetium Tc 99m Pentetate | 1999 |
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
16 trial(s) available for captopril and aspirin
Article | Year |
---|---|
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
Topics: Adult; Aged; Aspirin; Calcium Channel Blockers; Captopril; Cardiomegaly; Cardiovascular Agents; Diltiazem; Drug Utilization; Female; Humans; Male; Middle Aged; Myocardial Infarction; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; United States | 1992 |
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arm; Aspirin; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Drug Interactions; Female; Heart Failure; Hemodynamics; Humans; Indocyanine Green; Leg; Male; Middle Aged; Prostaglandins; Regional Blood Flow | 1994 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation | 1994 |
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Captopril; Cardiac Output, Low; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Morbidity; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Stroke Volume; Survival Rate; Time Factors; Ventricular Function, Left | 1993 |
Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients.
Topics: Adult; Aldosterone; Aspirin; Captopril; Cross-Over Studies; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Renin; Thromboxane B2 | 1994 |
[The evaluation of the hemodynamic effects of captopril one year after a myocardial infarct].
Topics: Adult; Aged; Aspirin; Captopril; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Portugal; Time Factors | 1994 |
Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril.
Topics: Adult; Aspirin; Blood Platelets; Blood Pressure; Captopril; Double-Blind Method; Drug Interactions; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Thromboxane B2; Thromboxanes | 1993 |
Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure; Captopril; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Epoprostenol; Female; Humans; Iodine Radioisotopes; Nitric Oxide; Radioimmunoassay; Stimulation, Chemical | 1996 |
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Female; Humans; Hydroxybutyrate Dehydrogenase; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ventricular Function, Left | 1998 |
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Coronary Disease; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Israel; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Risk Factors; Survival Rate | 1999 |
The possibility of captopril and aspirin test for the diagnosis of patients with renovascular hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Aspirin; Captopril; Humans; Hypertension, Renovascular; Middle Aged; Radionuclide Imaging | 1999 |
Tc-99m DTPA acetylsalicylic acid (aspirin) renography in the detection of renovascular hypertension.
Topics: Adolescent; Adult; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Female; Humans; Hypertension, Renovascular; Kidney; Male; Middle Aged; Prostaglandin Antagonists; Radioisotope Renography; Radiopharmaceuticals; Renal Circulation; Technetium Tc 99m Pentetate | 2000 |
Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Drug Interactions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prostaglandins | 2003 |
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Fibrinolytic Agents; Forearm; Heart Failure; Humans; Platelet Aggregation Inhibitors; Plethysmography; Vasodilation; Veins | 2005 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
50 other study(ies) available for captopril and aspirin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.
Topics: Aged; Aspirin; Blood Flow Velocity; Captopril; Creatinine; Drug Therapy, Combination; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Myocardial Ischemia | 1992 |
Angiotensin-converting enzyme inhibitors and renal function in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure; Captopril; Dipeptides; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Inulin; Kidney; Lisinopril; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Retrospective Studies | 1992 |
Kallikrein-thrombolytic and hypotensive action in cats--preliminary results.
Topics: Animals; Antihypertensive Agents; Aprotinin; Aspirin; Blood Pressure; Captopril; Cats; Epoprostenol; Female; Fibrinolytic Agents; Injections, Intravenous; Kallikreins; Male | 1990 |
Therapeutic significance of laboratory results in rheumatic disease.
Topics: Anti-Inflammatory Agents; Arthritis, Reactive; Aspirin; Blood Viscosity; C-Reactive Protein; Captopril; Ceruloplasmin; Clofibrate; Gene Frequency; Gold Sodium Thiomalate; Histidine; HLA Antigens; HLA-B27 Antigen; Humans; Hydroxychloroquine; Phenylacetates; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Sulfhydryl Compounds; Uveitis | 1985 |
Role of prostaglandins in the activity of some cardiovascular drugs.
Topics: Angiotensin II; Antihypertensive Agents; Aspirin; Captopril; Dinoprostone; Dipyridamole; Epoprostenol; Humans; Indomethacin; Kinins; Nitroglycerin; Peptidyl-Dipeptidase A; Platelet Aggregation; Prostaglandins; Prostaglandins E; Thromboxane-A Synthase | 1985 |
Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats.
Topics: Animals; Aspirin; Blood Pressure; Captopril; Diuresis; Drinking; Drug Synergism; Electrolytes; Hypertension; Male; Prostaglandins; Rats; Rats, Inbred SHR; Renin | 1987 |
[Mechanisms regulating the release of deaggregating prostanoids].
Topics: Adrenergic beta-Antagonists; Almitrine; Angiotensins; Animals; Arachidonic Acids; Aspirin; Atropine; Captopril; Cats; Cells, Cultured; Choline; Drug Interactions; Epoprostenol; Female; Indomethacin; Male; Piperazines; Platelet Aggregation; Prostaglandins; Prostaglandins E; Saralasin; Stimulation, Chemical | 1982 |
Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Biotransformation; Blood Pressure; Captopril; Colon; Diet; Female; Guinea Pigs; Male; Proline | 1982 |
Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy.
Topics: Animals; Aspirin; Bromelains; Captopril; Carrageenan; Kininogens; Kinins; Male; Molecular Weight; Pleural Effusion; Pleurisy; Prekallikrein; Rats; Rats, Inbred Strains | 1983 |
Enhanced blood pressure increase after prostaglandins synthesis inhibition in the early phase of renal hypertension; an opposing role for the contralateral kidney.
Topics: Animals; Aspirin; Blood Pressure; Captopril; Heart Rate; Hypertension, Renal; Kidney; Male; Prostaglandin Antagonists; Rats; Rats, Inbred Strains; Renin; Time Factors | 1984 |
The effect of prostaglandin synthesis inhibition of the acute blood pressure reduction by captopril in pentobarbital-anaesthetized rats.
Topics: Anesthesia; Animals; Aspirin; Blood Pressure; Captopril; Drug Interactions; Heart Rate; Indomethacin; Male; Pentobarbital; Proline; Prostaglandins; Rats; Time Factors | 1980 |
Failure of aspirin to modify the hypotensive action of captopril in spontaneously hypertensive rats.
Topics: Animals; Aspirin; Blood Pressure; Captopril; Hypertension; Male; Proline; Rats; Rats, Inbred Strains | 1981 |
Inhibition by nicotine of the vasodilator effect of bradykinin: evidence for a prostacyclin-dependent mechanism.
Topics: Animals; Aspirin; Blood Pressure; Bradykinin; Captopril; Coronary Circulation; Drug Interactions; Epoprostenol; Female; Guinea Pigs; In Vitro Techniques; Male; Nicotine; Prostaglandins; Rabbits; Vasodilator Agents | 1982 |
Endogenous BK stimulates ischemically sensitive abdominal visceral C fiber afferents through kinin B2 receptors.
Topics: Afferent Pathways; Animals; Aspirin; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cats; Ischemia; Nerve Fibers; Oligopeptides; Portal Vein; Receptors, Bradykinin; Viscera | 1994 |
Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Arterioles; Aspirin; Captopril; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases | 1995 |
Magnesium and myocardial infarction.
Topics: Aspirin; Captopril; Drug Therapy, Combination; Heparin; Humans; Magnesium; Myocardial Infarction; Streptokinase | 1994 |
Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Aspirin; Captopril; Dinoprost; Dipeptides; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Femoral Artery; In Vitro Techniques; Indans; Isometric Contraction; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; omega-N-Methylarginine; Oxyhemoglobins; Superoxide Dismutase | 1994 |
Intrarenal infusions of endothelin in conscious dogs: interactions with prostanoids and angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Captopril; Cyclooxygenase Inhibitors; Diuresis; Dogs; Dose-Response Relationship, Drug; Endothelins; Glomerular Filtration Rate; Ibuprofen; Infusions, Intra-Arterial; Male; Prostaglandins; Renal Circulation; Sodium; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Carotid occlusion mimicking giant cell arteritis.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blindness; Captopril; Carotid Artery Diseases; Carotid Artery, Internal; Constriction, Pathologic; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Ultrasonography, Doppler | 1998 |
I take Adalat (or nifedipine, also sold as Procardia) and captopril tablets daily for my high blood pressure. My physician told me not to take aspirin because of the possibility of drug interactions. From what I have read about aspirin, I hate to miss out
Topics: Aspirin; Captopril; Drug Interactions; Humans; Hypertension; Nifedipine | 1998 |
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ventricular Function, Left | 1999 |
Effects of captopril and bradykinin on chorda tympani-induced salivation in cat.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cats; Chorda Tympani Nerve; Cyclooxygenase Inhibitors; Electric Stimulation; Enzyme Inhibitors; Female; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Salivation; Submandibular Gland | 1999 |
Aspirin renography in the diagnosis of renovascular hypertension: a comparative study with captopril renography.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Aspirin; Captopril; Child; False Positive Reactions; Female; Humans; Hypertension, Renovascular; Male; Radioisotope Renography; Radiopharmaceuticals; Renal Artery Obstruction; Technetium Tc 99m Pentetate | 2000 |
Aspirin renography and captopril renography in the diagnosis of renal artery stenosis.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Radioisotope Renography; Radiopharmaceuticals; Renal Artery Obstruction; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Mertiatide | 2000 |
Myopericarditis associated with streptococcal tonsilitis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Captopril; Humans; Male; Penicillin V; Penicillins; Pericarditis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2001 |
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Captopril; Disease Models, Animal; Endothelium, Vascular; Female; Hemodynamics; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Vasodilation; Ventricular Fibrillation | 2003 |
The effect of acetylsalicylic acid and captopril on uterine and ovarian blood flow during the estrous cycle in mares.
Topics: Animals; Anticoagulants; Aspirin; Captopril; Estrous Cycle; Female; Horses; Ovary; Placebos; Progesterone; Pulsatile Flow; Uterus; Vasodilator Agents | 2004 |
Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Capillaries; Captopril; Coronary Circulation; Glucocorticoids; Heart Rate; Hypertrophy, Left Ventricular; Imidazoles; Male; Methylprednisolone; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Wistar; Sympatholytics | 2004 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Biomarkers; Captopril; Child; Coronary Angiography; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography; Electrocardiography; Humans; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 2009 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Early Medical Intervention; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Ramipril; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Risk Factors; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus.
Topics: Animals; Aspirin; Atorvastatin; Captopril; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Metformin; Neuroprotective Agents; Rats; Rats, Wistar; Streptozocin | 2019 |